Xencor, Inc.

XNCR·NasdaqGM
Compare
25.04+0.41 (+1.66%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours24.84−0.20 (−0.81%)Oct 12, 7:22 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close24.63
Open24.64
Day range24.4425.32
52-week range10.3830.61
Off day high−1.11%
Off 52-week high−18.20%
Volume752.23K
Avg. volume (3M)1.33M
Market cap1.86B
EPS (TTM)-2.16
Forward P/E-7.04
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding74.35M
Short interest—
Earnings dateAug 5, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
XNCR OABI ZYME IDYA CRVS PGEN
Market cap 1.86B 693.51M 1.82B 3.48B 845.42M 2.74B
P/E (TTM) — — — — — —
Forward P/E -7.0 -16.3 24.0 -9.0 -9.4 -34.8
Price/book 3.7 2.7 22.5 2.9 3.8 62.8
Dividend yield — — — — — —
1-year change +76.43% +195.68% +42.41% +34.89% +47.96% +143.30%
Today +1.66% −0.42% −1.78% −0.14% −4.47% −1.92%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Xencor's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
OmniAb, Inc.OABI · Biotechnology 693.51M 4.7700 −0.42%
Zymeworks Inc.ZYME · Biotechnology 1.82B 25.33 −1.78%
IDEAYA Biosciences, Inc.IDYA · Biotechnology 3.48B 36.06 −0.14%
Corvus Pharmaceuticals, Inc.CRVS · Biotechnology 845.42M 10.05 −4.47%
Precigen, Inc.PGEN · Biotechnology 2.74B 7.66 −1.92%
Arcus Biosciences, Inc.RCUS · Biotechnology 3.06B 24.34 −0.29%
AbCellera Biologics Inc.ABCL · Biotechnology 4.09B 12.64 +0.72%
X4 Pharmaceuticals, Inc.XFOR · Biotechnology 279.59M 2.8200 −3.09%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Intellia Therapeutics, Inc.NTLA · Cambridge, MA 1.76B 12.58 −3.75%
Biohaven Ltd.BHVN · New Haven, CT 1.78B 11.81 −2.24%
Generate Biomedicines, Inc.GENB · Somerville, MA 1.78B 13.84 −3.49%
Structure Therapeutics Inc.GPCR · South San Francisco, CA 1.71B 23.91 −6.38%
Zymeworks Inc.ZYME · Middletown, DE 1.82B 25.33 −1.78%
Mesoblast LimitedMESO · Melbourne, VIC 1.85B 14.27 −0.14%
Braveheart Bio, Inc.BRVE · San Francisco, CA 1.83B 20.36 +1.70%
UroGen Pharma Ltd.URGN · Princeton, NJ 1.87B 38.28 +3.94%

Also based in Pasadena, California, then elsewhere in California.

Company Mkt cap Price Today
East West Bancorp, Inc.EWBC · Pasadena, CA 17.20B 125.56 +0.02%
Arrowhead Pharmaceuticals, Inc.ARWR · Pasadena, CA 8.58B 60.73 −3.22%
Tetra Tech, Inc.TTEK · Pasadena, CA 8.57B 33.49 +0.45%
Alexandria Real Estate Equities, Inc.ARE · Pasadena, CA 7.59B 44.12 −3.05%
Dine Brands Global, Inc.DIN · Pasadena, CA 377.50M 29.82 +1.60%
NVIDIA CorporationNVDA · Santa Clara, CAOdds 5.46T 226.32 −1.29%
Apple Inc.AAPL · Cupertino, CAOdds 4.98T 340.97 +1.29%
Alphabet Inc.GOOG · Mountain View, CA 4.27T 348.97 +0.32%

The stocks whose daily moves over the past year went most closely with Xencor's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Arcus Biosciences, Inc.RCUS · Correlation 0.49 3.06B 24.34 −0.29%
Corvus Pharmaceuticals, Inc.CRVS · Correlation 0.45 845.42M 10.05 −4.47%
Enanta Pharmaceuticals, Inc.ENTA · Correlation 0.43 358.24M 12.30 −1.60%
IDEAYA Biosciences, Inc.IDYA · Correlation 0.42 3.48B 36.06 −0.14%
AbCellera Biologics Inc.ABCL · Correlation 0.41 4.09B 12.64 +0.72%
AnaptysBio, Inc.ANAB · Correlation 0.37 1.38B 46.04 +0.20%
Zymeworks Inc.ZYME · Correlation 0.37 1.82B 25.33 −1.78%
Palvella Therapeutics, Inc.PVLA · Correlation 0.35 1.94B 134.38 −3.16%

What visitors to Xencor's page also look at.

Company Mkt cap Price Today
MacroGenics, Inc.MGNX 236.96M 3.7200 −0.53%
Enanta Pharmaceuticals, Inc.ENTA 358.24M 12.30 −1.60%
AnaptysBio, Inc.ANAB 1.38B 46.04 +0.20%
REGENXBIO Inc.RGNX 512.92M 7.77 −3.72%
Syndax Pharmaceuticals, Inc.SNDX 1.48B 16.55 −2.59%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All XNCR news ›
Seeking Alpha·Positive

Xencor: Better Funding For Obexelimab

Xencor's settlement with Alexion helped improve its runway, which should be enough to reach obexelimab’s FDA PDUFA decision. Read more on XNCR stock here. - Xencor’s antibody platform supports its in-house oncology and immunology pipeline.…

Xencor·Positive

Xencor Reports Second Quarter 2026 Financial Results

-- XmAb819 ccRCC expansion cohorts to be presented in an oral session at ESMO 2026; multiple Phase 1 sub-studies in earlier lines of therapy and additional indications now open for enrollment or planned -- -- XmAb942 enrollment in…

MarketBeat·Positive

Wells Fargo & Company Initiates Coverage on Xencor (NASDAQ:XNCR)

Analysts at Wells Fargo & Company began coverage on shares of Xencor (NASDAQ:XNCR - Get Free Report) in a note issued to investors on Wednesday. The firm set an "overweight" rating and a $55.00 price target on the biopharmaceutical…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Mentioned with

Novo Nordisk2Astrazeneca1Avenue Capital1Bank of America1Biodexa Pharmaceuticals Plc1Biopharma Holdings, Inc.1Boston Scientific1Boston Scientific Corporation1

People in the coverage

Adam Craig1Adi Mor1Alan Simpson1Belvisi1Benji Taylor1Billy Eckert1

Themes

Financial2Reports2Results2Analysis1Announces1Biopharma1Biotech1CNBC1

Most coverage from

  1. investors.xencor.com1
  2. marketbeat.com1
  3. seekingalpha.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.